You have 9 free searches left this month | for more free features.

newly diagnosed

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer, Newly-Diagnosed Prostate Cancer Trial ([18F]PSMA-1007)

Not yet recruiting
  • Prostate Cancer
  • Newly-Diagnosed Prostate Cancer
  • (no location specified)
Nov 3, 2023

Feasibility Trial in Glostrup (NISMA)

Completed
  • Feasibility
  • NISMA
  • Glostrup, Region Hovedstaden, Denmark
    Luise Holberg Lindgren
Sep 26, 2023

nk/T-cell Lymphoma, Newly Diagnosed, Advanced Lymphoma Trial in Beijing (XPO1 inhibitor)

Recruiting
  • nk/T-cell Lymphoma
  • +2 more
  • XPO1 inhibitor
  • Beijing, Haidian, China
    ChinaPLAGH
Apr 18, 2023

Multiple Sclerosis Trial in Istanbul (Structured exercise training)

Not yet recruiting
  • Multiple Sclerosis
  • Structured exercise training
  • Istanbul, Turkey
    Feray Güngör
Jul 16, 2023

Newly Diagnosed Peripheral T-cell Lymphoma Trial in Wuhan (Duvelisib, Chidamide)

Recruiting
  • Newly Diagnosed Peripheral T-cell Lymphoma
  • Duvelisib, Chidamide
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Jul 27, 2023

Multiple Sclerosis (MS) Trial in Birmingham (Physical activity behavioral intervention in persons newly diagnosed with MS)

Recruiting
  • Multiple Sclerosis (MS)
  • Physical activity behavioral intervention in persons newly diagnosed with MS
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 24, 2023

Newly Diagnosed Peripheral T-cell Lymphoma Trial in Nanjing (CMOP+Chidamide)

Recruiting
  • Newly Diagnosed Peripheral T-cell Lymphoma
  • Nanjing, Jiangsu, China
    Hematological Department, People's Hospital of Jiangsu Province
Jun 1, 2023

Oncology, Psychological Distress Trial (mHealth-delivered music breathing therapy, Online educational modules)

Not yet recruiting
  • Oncology
  • Psychological Distress
  • mHealth-delivered music breathing therapy
  • Online educational modules
  • (no location specified)
Sep 19, 2023

Type 1 Diabetes, Type 1 Diabetes (Juvenile Onset), Diabetes, Type 1 Trial in Indianapolis (HAMS-AB, Placebo)

Not yet recruiting
  • Type 1 Diabetes
  • +2 more
  • Indianapolis, Indiana
    Indiana School of Medicine
Sep 28, 2023

Glioblastoma Multiforme Trial (WP1066)

Not yet recruiting
  • Glioblastoma Multiforme
  • (no location specified)
May 18, 2023

Light Chain (AL) Amyloidosis, CCND1 Translocation, Venetoclax Trial (Venetoclax, Dexamethasone Oral)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • +2 more
  • (no location specified)
Aug 16, 2023

Non-hodgkin Lymphoma Trial (Methotrexate, Rituximab (where available), Ibrutinib)

Not yet recruiting
  • Non-hodgkin Lymphoma
  • (no location specified)
Aug 11, 2023

HIV, Hiv Trial (Community Antiretroviral Therapy)

Not yet recruiting
  • HIV Infections
  • Hiv
  • Community Antiretroviral Therapy
  • (no location specified)
Nov 6, 2023

Newly Diagnosed Glioblastoma Trial ([177Lu]Lu-NeoB, [68Ga]Ga-NeoB, Temozolomide)

Not yet recruiting
  • Newly Diagnosed Glioblastoma
  • (no location specified)
Feb 13, 2023

Positron Emission Radiomics With PSMA Radioligands on Newly

Not yet recruiting
  • Prostate Cancer
  • Immunohistochemistry (IHC) analysis
  • (no location specified)
Apr 6, 2023

Classic Hodgkin Lymphoma Trial (Concurrent penpulimab and AVD, Sequential penpulimab and AVD)

Not yet recruiting
  • Classic Hodgkin Lymphoma
  • Concurrent penpulimab and AVD
  • Sequential penpulimab and AVD
  • (no location specified)
Jul 10, 2023

Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)

Not yet recruiting
  • Acute Myeloid Leukemia in Children
  • Standard Intervention
  • Investigational Intervention
  • (no location specified)
Aug 8, 2023

AI-ECG in a NEwly Diagnosed Heart Failure

Recruiting
  • Heart Failure
  • Eko DUO
  • London, United Kingdom
    Imperial College London
Apr 4, 2023

Type 1 Diabetes Trial in Sacramento (personalized comprehensive diabetes support)

Enrolling by invitation
  • Type 1 Diabetes
  • personalized comprehensive diabetes support
  • Sacramento, California
    University of California Davis
Sep 24, 2023

PCNSL Trial in Shanghai (Zanubrutinib, Rituximab, Methotrexate)

Not yet recruiting
  • PCNSL
  • Shanghai, Shanghai, China
    Ruijin Hospital
Jun 8, 2023

Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia Trial in Xi'an (Olverembatinib plus venetoclax and dexamethasone)

Recruiting
  • Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia
  • Olverembatinib plus venetoclax and dexamethasone
  • Xi'an, Shannxi, China
    Department of Hematology, Xijing Hospital, Fourth Military Medic
Oct 9, 2023

Guiding the Treatment in Older Newly Diagnosed Multiple Myeloma

Not yet recruiting
  • Multiple Myeloma
  • Frailty
    • (no location specified)
    Oct 30, 2023

    Newly Diagnosed MGMT Unmethylated Glioblastoma Trial in Durham (D2C7-IT, 2141-V11)

    Not yet recruiting
    • Newly Diagnosed MGMT Unmethylated Glioblastoma
    • Durham, North Carolina
      Duke University Medical Center
    Feb 7, 2023

    Newly-diagnosed PCNSL Treated WithMethotrexate and

    Active, not recruiting
    • Primary Central Nervous System Lymphoma
    • Shanghai, China
      Department of Hematology, Huashan Hospital, Fudan University
    Oct 30, 2023

    Type 2 Diabetes Trial in Roma (flash glucose monitoring continuous, capillary blood test, flash glucose monitoring intermittent)

    Recruiting
    • Type 2 Diabetes
    • flash glucose monitoring continuous
    • +2 more
    • Roma, Italy
      Fondazione Policlinico Universitario Campus Bio-Medico
    Oct 18, 2023